Epicore has raised a total of $32 million in Series B funding, with significant backing from notable investors and partnerships with Fortune 1000 companies.
Organizations Involved
Fortune 1000 companies, Department of Defense, National Institute of Health
Company Description
Epicore Biosystems is a digital health company developing advanced sweat-sensing wearables that provide real-time personalized health insights. Their clinically validated biowearable solutions and cloud analytics are deployed globally and licensed by leading Fortune 1000 companies, the Department of Defense, and the National Institute of Health.
Market
Health Wearables
Location
Cambridge,
MA,
USA
Coinvestors
San Francisco-based investor, marquee angel investors, Alumni Ventures, Joyance Partners